We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
BioTek Awarded Patent for Hybrid Technology™
Product News

BioTek Awarded Patent for Hybrid Technology™

BioTek Awarded Patent for Hybrid Technology™
Product News

BioTek Awarded Patent for Hybrid Technology™


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "BioTek Awarded Patent for Hybrid Technology™"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

BioTek has been awarded US patent 8,218,141 covering the combination of two alternate paths for light within the same analytical instrument.

Known as Hybrid Technology™, the patented functionality is available in BioTek's Synergy™ NEO HTS Multi-Mode Microplate Reader and in the Synergy H4 and H1 Hybrid Multi-Mode Microplate Readers.

Using Hybrid Technology, light can be directed to and from the microplate samples through a filter-based optical system or through a monochromator-based optical system for wavelength selection.

This two-optical-path system provides optimal performance and flexibility for a wide range of applications in fluorescence microplate assays.

BioTek's Synergy readers are modular platforms that can include Fluorescence Intensity, UV-Vis Absorbance, Luminescence, TRF, TR-FRET and FP detection modes.

Advertisement